Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Market Vectors® Pharmaceutical ETF (PPH)

Delayed Data
As of 3:59pm ET
 -0.13 / -0.20%
Today’s Change
Today|||52-Week Range
PPH Regular Dividend: PPH began trading ex-dividend on 10/01/15. A $0.284 dividend will be paid to shareholders of record as of 10/05/15.

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.


1 month-4.09% 3 years+19.47%
3 months-9.37% 5 years--
1 year+5.19% Since inception+19.47%
Data through 10/03/2015

Quote Details

Previous close$64.47
Open day’s range63.86 – 64.93
Net asset value (NAV)64.50 (10/02/2015)
Daily volume65,029
Average volume (3 months)60,462
Data as of 3:59pm ET, 10/05/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+26.72%
Expense Gross exp ratio0.42%0.46%
Risk 5 year sharpe ratio--1.60
Net assets$369.9M$1.9B
Average market cap$85.8B$33.2B
Average P/E23.124.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
NVS Novartis7.84%
JNJ Johnson & Johnson6.77%
PFE Pfizer5.47%
AGN Allergan5.34%
SNY Sanofi5.12%
TEVA Teva Pharmaceutical5.06%
NVO Novo Nordisk5.05%
GSK GlaxoSmithKline5.04%
ABBV AbbVie4.84%
-- 4.80%

Partner Offers